Table of Contents
Volume 2 | Issue 1
Publication Date: August 2000- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
10 |
Non–Small-Cell Lung Cancer, Have We Reached a “Chemotherapy Efficacy Plateau”? Chandra P. Belani |
|
Meeting Highlights | ||
16-20 |
Highlights From: 36th Annual ASCO Meeting, New Orleans, LA Maxine D. Fisher, Amy D’Orazio |
|
Researches in Brief | ||
21-22 |
Phase II and III Trials, Comparison of Four Chemotherapy Regimens in Advanced Non–Small-Cell Lung Cancer (ECOG 1594) CIG Media Group |
|
23-24 |
Irinotecan and Cisplatin Versus Etoposide and Cisplatin in Small-Cell Lung Cancer: JCOG 9511 CIG Media Group |
|
25-26 |
Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer (SWOG 9504) CIG Media Group |
|
Comprehensive Reviews | ||
29-40 |
Treatment of Brain Metastases in Patients with Small-Cell Lung Cancer: Lessons from Treatment of Other Tumors Henry Wagner Jr. |
|
43-47 |
The Role of Gemcitabine and Paclitaxel as Second-Line Chemotherapy for the Treatment of Advanced Non–Small-Cell Lung Cancer (NSCLC) Stylianos Kakolyris, Vassilis Georgoulias |
|
Original Contribution | ||
48-52 |
Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer Joseph J. Merchant, KyungMann Kim, Minesh P. Mehta, Gregory H. Ripple, Marilyn L. Larson, Diane J. Brophy, Lana C. Hammes, Joan H. Schiller |
|
Commentaries | ||
53-54 |
Commentary on “Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer” Ezra E. W. Cohen, Everett E. Vokes |
|
55 |
Commentary on “Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer” Gregory A. Masters |
|
Original Contribution | ||
56-60 |
Total Videothoracoscopic Lobectomy Versus Open Thoracotomy for Early-Stage Non–Small-Cell Lung Cancer James D. Luketich, Mindi A. Meehan, Rodney J. Landreneau, Neil A. Christie, John M. Close, Peter F. Ferson, Robert J. Keenan, Chandra P. Belani |
|
Commentary | ||
61 |
Commentary on “Total Videothoracoscopic Lobectomy Versus Open Thoracotomy for Early-Stage Non–Small-Cell Lung Cancer” Robert L. Quigley |
|
Original Contribution | ||
62-66 |
Phase II Study of Pyrazine Diazohydroxide (NSC 361456) for Advanced Non–Small-Cell Lung Cancer A. William Blackstock, Jose Acostamadiedo, Glenn Lesser, Frederick Richards, L. Douglas Case, Douglas R. White |
|
Brief Communication | ||
69-72 |
Randomized Trial of Surgery Versus Radiotherapy in Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer After a Response to Induction Chemotherapy. EORTC 08941 T.A.W. Splinter, P.E. van Schil, G.W.P.M. Kramer, J. van Meerbeeck, A. Gregor, P. Rocmans, A. Kirkpatrick |
|
Commentary | ||
73 |
Commentary on “Randomized Trial of Surgery Versus Radiotherapy in Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer After a Response to Induction Chemotherapy. EORTC 08941” Rafael Rosell |
|
Current Trials | ||
74-77 |
HER2/neu Peptide-Based Vaccines, with GM-CSF as an Adjuvant, in Patients with Advanced-Stage HER2/neu-Expressing Cancers Kathy Schiffman, Mary L. Disis |
|